Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04127175
Other study ID # 2019/629
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date October 1, 2019
Est. completion date August 2020

Study information

Verified date July 2020
Source Corporacion Parc Tauli
Contact Oliver Diaz, PhD
Phone +34 93 402 08 55
Email oliver.diaz@ub.edu
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Breast cancer (BC) is the most frequently diagnosed cancer in women worldwide. The cause of developing BC is currently unknown. However, there are several risk factors, such as volumetric breast density (VBD), which have been proved to have a relationship with BC. The assessment of breast density is typically performed subjectively using the 4-classes density classification described by American College of Radiology. However, in the last years, automated breast density software tools have been developed (e.g. Volpara, Quantra). In this work, VBD measurements from VolparaTM (v. 1.5.4.0) will be compared between Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) of the same pacient ('combo mode'). Images will be acquired in a Hologic Selenia Dimensions, the most common FFDM/DTB system, where image resolution is different for FFDM (70 um) and DBT (140 um).

This study (1) evaluates the consistency between Volpara's breast density measurements and spatial distribution for the two imaging techniques (FFDM and DBT) in a Hologic Selenia Dimensions, and (2) compares VDB measurements with other similar tool (Quantra) and radiologists breast density manual classification.


Description:

Monocentric, prospective and observational study which will analyse a series of 300 cases (FFDM + DBT) from consecutive women. Image acquisitions will take place within the Área de radiología Mamaria y Ginecológica located at Parc Taulí Hospital Universitari, Sabadell. The purposes of this study will be explained to each potential candidate and if agreed to participate, a consent form will be signed.

Inclusion criteria:

- Subjects over 18 years old.

- Acceptance of participation through a signed consent form.

- Asymptomatic subjects

Exclusion criteria:

- Subjects refusing to participate or sign the consent form.

- Subjects with prior history of breast surgery or biopsy with markers.

- Subjects with breast prostheses.


Recruitment information / eligibility

Status Recruiting
Enrollment 300
Est. completion date August 2020
Est. primary completion date July 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 40 Years to 99 Years
Eligibility Inclusion Criteria:

- Acceptance of participation through a signed consent form.

- Asymptomatic subjects

Exclusion Criteria:

- Subjects refusing to participate or sign the consent form.

- Subjects with prior history of breast surgery or biopsy with markers.

- Subjects with breast prostheses.

- Subjects with biopsy marker clips

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Volpara
This tool represents a physics-based model which extract pixel-wise information from the FFDM or DBT images, and combine it with metadata information from the DICOM header and appropriate linear attenuation coefficients of both adipose and glandular tissue.

Locations

Country Name City State
Spain Radiology Breast Unit, Hospital Parc Taulí Sabadell Barcelona

Sponsors (3)

Lead Sponsor Collaborator
Corporacion Parc Tauli Universitat de Girona, University of Barcelona

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Consistency of breast density measurements from the latest VolparaTM breast density tool for Hologic's FFDM and DBT images (i.e. combo mode). 1 year
Primary Comparison of VolparaTM's Volumetric Breast Density measurements and its 4-classes density rating measured in DBT against QuantraTM 3D and radiologist's BI-RADS manual classification 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT04904757 - Contrast-enhanced Spectral Mammography (CESM) Breast Cancer Screening N/A
Completed NCT00470561 - Effect of Aspirin on Mammogram Density in Healthy Postmenopausal Women With a Moderate or High Level of Breast Density N/A
Recruiting NCT04498013 - Study of the Effects of Cyclodynon on Reducing the Cumulative Risk of Breast Cancer Development in a Female Aged 40-52 Phase 4
Terminated NCT03199963 - Trial of 4-Hydroxytamoxifen (4-OHT) Gel in Women Aimed at Reducing Dense Breast Tissue Phase 3
Completed NCT04616430 - Topical Endoxifen in Women Phase 2